Immsi S.p.A (IMS) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Immsi S.p.A €0.58, price €0.52, upside +10.7%, quality 45 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Immsi S.p.A for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Immsi S.p.A. operates in the real estate, industrial, and naval sectors in Italy, the rest of Europe, India, the United States, and internationally.
Show more
Immsi S.p.A. operates in the real estate, industrial, and naval sectors in Italy, the rest of Europe, India, the United States, and internationally. The company engages in the production and distribution of scooters, motorcycles, and light commercial vehicles; real estate development projects; Is Molas tourist hotel complex management; and production of defense ships, such as mine countermeasure vessels, fast patrol boats, hydrofoils, and fast ferries. It also offers two-wheeler vehicles under the Aprilia, Derbi, Gilera, Moto Guzzi, Piaggio, Scarabeo, and Vespa brand names; and commercial vehicles under the Ape brand names. The company was founded in 2000 and is based in Mantua, Italy. Immsi S.p.A operates as a subsidiary of Omniainvest S.p.A.
Stock analysis
Immsi S.p.A (IMS) currently trades at €0.5240, while our model-based Fair Value estimate is €0.5800, implying the stock looks roughly 9.7% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €2.64 per share, and 3 of the 10 models we run sit above the €0.5240 price.
Bear case: the Dividend Discount group reads lowest at €0.1000, and 7 of the 10 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 45/100 (below-average quality), in the Consumer Cyclical sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Immsi S.p.A reported revenue of €1.6B in FY2025 versus €1.7B in FY2021, a compound −1.8%/yr. Reported net income was €98.0K in FY2025, compounding −77.1%/yr from FY2021.
Key figures
Market cap €178M · P/S ratio 0.12 · Dividend yield 2.2% · Net margin 0.0% · Return on equity 2.6% · Return on assets (EBIT) 5.7% · Operating margin 5.3% · Revenue (TTM) €1.6B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 24% below its 52-week high and 16% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −2% fair-value upside, at 11%, IMS screens cheaper than that median.
Fair Value models
Bear €0.5800Fair Value €0.5800Bull €0.5800
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.26/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−8.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.0%
Start year 2020 (pandemic). Over 10 years: +1.6% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+5.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.3%
Dividend (yield on the price)2.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 7%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Auto Manufacturers · 116 stocks
Beats the industry median on 5/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score45 · Below median
Fair Value upside+11% · Above median
Profitability
Return on equity (TTM)3% · Below median
Return on assets3% · Above median
Net margin (TTM)0% · Below median
Operating margin (TTM)5% · Above median
Growth and dividend
Revenue growth−4% · Below median
Dividend yield (TTM)2.2% · Below median
Balance sheet
Debt / equity3.64× · Highest 25%
Valuation Multiplesvs Auto Manufacturers median · lower = cheaper
P/B1.04× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Immsi S.p.A Fair Value". https://www.fairvalue-calculator.com/stock/IMS
Frequently asked questions
Is Immsi S.p.A (IMS) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of €0.5800 versus a price of €0.5240, about +11% upside (undervalued).
What is the fair value of IMS?
Our model-based fair value for Immsi S.p.A is €0.5800 (as of Sep 24, 2026), built from audited fundamentals. The current price: €0.5240.
What is the quality score of IMS?
Immsi S.p.A has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Immsi S.p.A (IMS)?
Our model-based price target is the fair value of €0.5800 (as of Sep 24, 2026) from 13 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Immsi S.p.A stock forecast for 2026?
Our models put fair value at €0.5800, about +11% upside versus a price of €0.5240 (undervalued). The calculation is refreshed regularly with new filings.
What is the revenue of Immsi S.p.A (IMS)?
Immsi S.p.A reported trailing-twelve-month revenue of about €1.6B (latest available figure, as of Sep 24, 2026).
Does Immsi S.p.A pay a dividend?
Immsi S.p.A currently shows a dividend yield of about 2.24% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Immsi S.p.A (IMS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Immsi S.p.A it is €0.5800 per share (as of Sep 24, 2026), against a price of €0.5240. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Immsi S.p.A stock overvalued or undervalued in 2026?
As of Sep 24, 2026, IMS trades below its calculated fair value: price €0.5240, fair value €0.5800, a gap of about +11% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of IMS?
No. The price is what the market pays today (€0.5240); the fair value is what the company's own numbers justify (€0.5800). For Immsi S.p.A the two are €0.0560 per share apart. That gap is exactly why we show both numbers side by side.
How much is Immsi S.p.A worth?
The market values Immsi S.p.A at about €178M (market capitalisation, as of Sep 24, 2026). Per share that is €0.5240; our models calculate a fair value of €0.5800 per share.
What is the PEG ratio of IMS?
The PEG ratio of Immsi S.p.A is 27.34 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Immsi S.p.A (IMS)?
Balance-sheet figures for Immsi S.p.A (as of Sep 24, 2026): return on equity 2.6%, debt of 3.64 per unit of equity. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is IMS from its 52-week high?
Immsi S.p.A trades at €0.5240, about 24% below its 52-week high of €0.6900 and 16% above the low of €0.4535 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of €0.5800 is for.
Which stocks are comparable to Immsi S.p.A?
From the same area (Consumer Cyclical) we also value Tesla, Inc, Toyota Motor Corporation, BYD Company, Hyundai Motor Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Immsi S.p.A stock attractive at the current price?
The data as of Sep 24, 2026: price €0.5240, calculated fair value €0.5800 (+11%), Quality Score 45/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of IMS calculated?
We run Immsi S.p.A through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €0.5800, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Immsi S.p.A currently trades 11 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Immsi S.p.A (IMS)?
The closing price on Sep 24, 2026 was €0.5240. Our model-based fair value is €0.5800, about +11% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Immsi S.p.A right now?
The price is below even our cautious bear case (€0.5800). The market is more pessimistic than our downside scenario. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Immsi S.p.A
How large is the market capitalisation of Immsi S.p.A (IMS)?
The market capitalisation of Immsi S.p.A is €178M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Immsi S.p.A (IMS)?
The price-to-sales ratio of Immsi S.p.A is 0.12 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Immsi S.p.A (IMS)?
The dividend yield of Immsi S.p.A is 2.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Immsi S.p.A (IMS)?
The net margin of Immsi S.p.A is 0.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Immsi S.p.A (IMS)?
The return on equity (ROE) of Immsi S.p.A is 2.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Immsi S.p.A (IMS)?
On an EBIT basis the return on assets of Immsi S.p.A is 5.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Immsi S.p.A (IMS)?
The operating margin of Immsi S.p.A is 5.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Immsi S.p.A (IMS)?
Revenue at Immsi S.p.A is growing −4.2% versus a year earlier (3y avg −9.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Immsi S.p.A (IMS)?
Earnings per share at Immsi S.p.A are growing −24.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Immsi S.p.A (IMS) generate?
The free cash flow of Immsi S.p.A is −€13.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Immsi S.p.A (IMS) carry?
The net debt of Immsi S.p.A is €974M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Immsi S.p.A in the live analysis
One click puts Immsi S.p.A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
